Abscesos

Allantoin has been used in acne-relevant formulations for its soothing, anti-irritant, and keratolytic properties. A double-blind trial found that an allantoin and panthenol combination led to significant lesion count reduction and skin texture improvement after 4 weeks in subjects with mild acneiform lesions. The aluminum salt of allantoin has also been specifically noted as an effective acne treatment component.

Aloe vera gel has been used topically for acne as a traditional wound-healing and anti-inflammatory agent, and has been validated in clinical trials. A 2022 systematic review of herbal medicine RCTs for acne (34 trials, 1,753 participants) found aloe vera significantly reduced total acne lesion counts compared to placebo. A propolis–tea tree oil–aloe vera combination was also shown in two double-blind RCTs to outperform erythromycin cream.

Alpha hydroxy acids (AHAs), including glycolic acid, are used topically for acne due to their keratolytic and comedolytic properties. A Cochrane systematic review of 49 RCTs covering topical acne treatments including AHAs confirmed their clinical evaluation in acne management. They exfoliate the stratum corneum, reducing follicular plugging.

Azelaic acid (20% cream, 15% gel) is an FDA-indicated topical treatment for acne vulgaris with antibacterial, anti-inflammatory, and keratolytic mechanisms. A 2023 systematic review of 43 RCTs confirmed its efficacy in reducing both inflammatory and non-inflammatory lesions. Efficacy is comparable to topical retinoids with superior tolerability.

A small randomized controlled trial found that oral aqueous barberry extract (600 mg/day for 4 weeks) reduced total acne lesion counts by approximately 45% in adolescents with moderate-to-severe acne vulgaris. Berberine's antilipogenic effects on sebaceous glands and anti-inflammatory actions are proposed mechanisms. Evidence is promising but limited to a single small trial.

Basil essential oil has demonstrated antibacterial activity against Cutibacterium acnes (formerly Propionibacterium acnes) and other skin pathogens in vitro. A PubMed-indexed clinical study evaluated an antimicrobial formulation combining sweet basil and orange essential oils for acne, with results rated good to excellent. The anti-inflammatory and antimicrobial properties of basil constituents such as linalool and eugenol underpin this use.

Berberine, an isoquinoline alkaloid from Berberis species, has demonstrated antimicrobial activity against C. acnes, anti-inflammatory effects, and beneficial outcomes in acne patients, including those with PCOS-related hormonal acne. A 4-week RCT with 25 participants with moderate-to-severe acne tested Berberis vulgaris. In vitro studies show MIC values of 6.25–12.5 μg/mL against C. acnes strains.

Clinical trials have examined topical and oral Nigella sativa for acne vulgaris. A 2022 systematic review and meta-analysis of RCTs covering multiple skin conditions including acne found an odds ratio of 4.59 (95% CI: 2.02–10.39) favouring N. sativa lotion over control. Antimicrobial and anti-inflammatory mechanisms are attributed primarily to thymoquinone.

A 10-week RCT published in Acta Dermato-Venereologica found that 400 mg GLA/day from borage oil significantly reduced both inflammatory and non-inflammatory acne lesions vs. placebo, with reduced IL-8 levels in skin samples. GLA's anti-inflammatory properties are proposed to modulate sebaceous gland activity and reduce acne-associated inflammation.

Burdock has long been used internally and topically for acne in both TCM and European herbalism. An observational clinical study (Miglani et al., 2014, Homeopathy) documented significant improvement in acne vulgaris with oral burdock supplementation. Antimicrobial activity against acne-associated bacteria and anti-inflammatory effects via phenolic acids provide mechanistic support. The EMA recognizes burdock as a traditional herbal medicine for seborrhoeic skin conditions similar to acne.

Camphor's documented antibacterial and anti-inflammatory properties give it a plausible role in acne management. Bioactive constituents such as 1,8-cineole, α-pinene, and camphene have shown antibacterial activity relevant to acne-causing organisms. A 2024 peer-reviewed review (MDPI Pharmaceuticals) confirmed camphor's anti-acne properties among its dermatological activities. Human clinical evidence remains limited.

Epidermal barrier dysfunction—characterized by reduced ceramide content and elevated transepidermal water loss (TEWL)—is documented in acne-affected skin and is further aggravated by standard topical acne medications such as adapalene and benzoyl peroxide. Ceramide-containing cleansers and moisturizers used adjunctively have been shown in double-blind clinical trials to reduce TEWL, dryness, erythema, and inflammatory lesion counts compared to controls. Ceramides are therefore positioned as adjuncts to acne therapy rather than standalone acne treatments.

Chaste tree is recognized by the German Commission E for the treatment of acne, particularly hormonally driven premenstrual acne. Its mechanism involves dopaminergic suppression of prolactin and indirect modulation of the progesterone-to-estrogen ratio. Dedicated placebo-controlled RCTs in acne specifically are limited and largely dated; the evidence is strongest from its approval in German regulatory practice and mechanistic studies.

Topical chlorophyll-a and sodium copper chlorophyllin have been tested in small human trials for acne vulgaris. A randomized, single-blind, split-face RCT found chlorophyll-a photodynamic therapy (PDT) reduced lesion counts and acne severity versus light therapy alone. A separate open-label pilot found 0.1% sodium copper chlorophyllin gel applied twice daily for 3 weeks produced statistically significant improvements in inflammatory and non-inflammatory lesions, pore size, and oiliness.

Topical sodium copper chlorophyllin complex has been evaluated in two small pilot studies for mild-to-moderate acne. A 2015 Journal of Drugs in Dermatology pilot trial (n=10, 3 weeks, 0.1% gel) showed statistically significant reductions in inflammatory and non-inflammatory lesion counts and pore size. A separate randomized split-face study also found chlorophyll-a used as a photosensitizer in photodynamic therapy significantly reduced acne lesion counts and sebum levels compared to LED light alone. Evidence is promising but limited to small pilots without placebo controls.

Clinical evidence links chromium supplementation to reduced acne severity, primarily in women with PCOS. A randomized double-blind, placebo-controlled trial found that 200 µg/day chromium picolinate for 8 weeks significantly reduced acne prevalence alongside inflammatory markers (hs-CRP, MDA) and improved antioxidant capacity. The likely mechanism is chromium's insulin-sensitizing effect, given the role of hyperinsulinaemia in driving androgen-mediated sebum production. Evidence is limited to PCOS populations and small samples.

Clove essential oil and eugenol have demonstrated in vitro antibacterial activity against skin pathogens relevant to acne. The anti-inflammatory properties of eugenol, including suppression of TNF-α and IL-6, are relevant to the inflammatory component of acne lesions. Published pharmacological reviews cite acne as a documented indication for clove essential oil use.

Omega-3 fatty acids reduce the inflammatory component of acne by suppressing leukotriene B4 and IL-1 production in skin. Vitamin A, related to the pharmaceutical acne treatment isotretinoin, regulates sebaceous gland activity. Small clinical studies support omega-3 supplementation reducing acne severity.

Commiphora mukul (guggul) has been evaluated in small clinical trials for nodulocystic acne. A head-to-head trial found oral gugulipid comparable to tetracycline, with patients with oily skin responding better to guggulsterone. Human evidence is limited in scale but documented.

In vitro studies demonstrate that Coptis chinensis extract and its berberine component suppress Propionibacterium acnes-induced inflammation in human keratinocytes. TCM traditionally used the herb for inflammatory skin conditions including acne. Mechanistic cell studies provide a scientific basis, though dedicated human RCTs for acne are limited.

Curcumin, the primary polyphenol of turmeric (Curcuma longa), has anti-inflammatory and antibacterial properties relevant to acne. A 2025 PMC clinical study evaluated a topical gel containing curcumin and clove oil vs. clindamycin in 31 participants with mild-to-moderate acne. Curcumin has been identified among plant-derived nutraceuticals with acne-relevant antioxidant, anti-inflammatory, and antibacterial properties in multiple systematic reviews.

DHA, a long-chain omega-3 fatty acid present in fish oil supplements studied for acne, contributes to the anti-inflammatory effects of omega-3 fatty acid supplementation shown to have fair-quality clinical evidence for acne in a 42-study systematic review covering 3,346 participants. It modulates inflammatory cytokine production and IGF-1-driven sebocyte lipogenesis.

DIM modulates estrogen and androgen metabolism, which may reduce hormonal drivers of acne such as excess sebum production. In vitro research published in Microbiology Spectrum (2022) demonstrates DIM inhibits Cutibacterium acnes biofilm formation. Clinical data are limited, with small studies suggesting reduced inflammatory lesions; larger RCTs are still needed.

In vitro research demonstrates that standardized E. purpurea extract (Echinaforce®) kills Propionibacterium acnes and suppresses the pro-inflammatory cytokine cascade the bacterium induces. The EMA HMPC monograph and official herbal monographs list mild acne among recognized indications. Evidence is currently preclinical and in vitro, not yet confirmed by clinical RCTs.

EGCG, the primary bioactive polyphenol in green tea, has been directly studied for acne, showing antimicrobial, anti-inflammatory, and sebum-suppressing effects. Clinical and in vitro evidence demonstrates it reduces C. acnes biofilm, suppresses sebocyte lipogenesis, and inhibits inflammatory cytokines. A 2019 mini-review confirmed clinical evidence for EGCG in inflammatory acne.

EPA, a long-chain omega-3 fatty acid, specifically reduces pro-inflammatory eicosanoid production relevant to acne inflammation. Clinical studies of combined EPA + EGCG + zinc supplementation in acne patients showed lesion reduction in 4/5 participants. EPA is part of omega-3 supplementation evaluated in RCTs for acne as a fair-quality evidence nutraceutical.

Clinical evidence for EPO in acne vulgaris itself is limited and a 2024 systematic review found it did not demonstrate effectiveness against acne. However, RCTs have shown EPO adjunct to isotretinoin therapy reduces isotretinoin-induced xerotic cheilitis and improves skin hydration markers. Its GLA content modulates sebaceous lipid composition, which has theoretical relevance to comedogenesis.

Geranium EO has demonstrated antibacterial activity against acne-related pathogens and is recognized for balancing sebum production. In vitro studies confirm its action against Staphylococcus aureus and other skin bacteria. It is widely used in clinical aromatherapy for oily and acne-prone skin.

Clinical data suggest GLA supplementation may reduce acne lesions, partly by restoring the skin barrier and reducing inflammatory mediators. A 10-week trial found that 2,000 mg/day of borage oil (containing ~400 mg GLA) significantly decreased breakouts and acne-related lesions. GLA is metabolized to DGLA, a precursor of anti-inflammatory prostaglandin E1 that suppresses pro-inflammatory cytokines. Evidence remains preliminary and more rigorous trials are needed.

Konjac glucomannan hydrolysates (GMH) have been studied as a topical spray formulation for acne vulgaris in a human trial (Bateni et al. 2013, American Journal of Dermatology and Venereology). A 5% GMH spray applied to 26 female volunteers with active acne showed significant improvement in acne severity index at 20 and 40 days. In vitro, GMH in combination with probiotics significantly inhibited Propionibacterium acnes growth.

Gotu Kola's purified madecassoside has been shown to reduce inflammatory cytokines relevant to acne pathogenesis. Its anti-inflammatory and collagen-regulating properties also address post-acne scarring. Used topically in formulations for acne-prone skin with a supporting mechanistic evidence base, though dedicated clinical acne RCTs are sparse.

Green tea, rich in EGCG (epigallocatechin-3-gallate), has antioxidant, anti-inflammatory, and antimicrobial effects relevant to acne. A systematic review and meta-analysis of RCTs evaluated green tea extract specifically for acne vulgaris. A nutraceutical systematic review (42 studies, 3,346 participants) identified green tea extract as one of four nutraceuticals with good-quality evidence for acne.

Guggul (as gugulipid) has been tested in small clinical trials for acne. A 1994 trial compared oral gugulipid to tetracycline in nodulocystic acne and found comparable outcomes. A more recent double-blind placebo-controlled study of 30 subjects taking 500 mg twice daily for 90 days showed significant reductions in both inflammatory and non-inflammatory lesion counts versus placebo.

Linalool, which constitutes ~95–99% of ho wood essential oil, has demonstrated antimicrobial activity against Staphylococcus aureus and Cutibacterium acnes (acne-causing bacteria) in vitro. Multiple sources confirm this bactericidal mechanism underpins ho wood's traditional use for skin blemishes.

Topical honey, particularly kanuka and manuka varieties, has antimicrobial activity against Cutibacterium acnes and has been tested in clinical trials for facial acne. A 2016 RCT (BMJ Open, n=136) tested 90% medical-grade kanuka honey on acne but did not show added clinical benefit over antibacterial soap alone. In vitro evidence supports antibacterial action, but robust human clinical proof of efficacy remains limited.

Myo-inositol reduces acne lesions primarily in women with PCOS by lowering hyperandrogenism and inhibiting 5-α reductase and COX-2 enzymes. Clinical trials in PCOS populations demonstrate significant reductions in both inflammatory and non-inflammatory lesion counts within 8–12 weeks. A 2024 systematic review in the Journal of Integrative Dermatology confirmed promising effectiveness for PCOS- and non-PCOS-related acne.

A 2024 systematic review in the Journal of Integrative Dermatology found that inositol (primarily myo-inositol) demonstrates promising effectiveness as adjunctive therapy for acne, including in PCOS-related and non-PCOS acne. Inositol nicotinate, when metabolized, releases inositol, providing the same active moiety. The mechanism involves inositol's ability to reduce insulin resistance and hyperandrogenism, key drivers of acne pathogenesis.

Sebum of acne patients is relatively deficient in linoleic acid (LA), and topical LA application has been shown in a double-blind, placebo-controlled RCT to reduce micro-comedone size by approximately 25% after one month. LA may act as a comedolytic agent by normalizing follicular keratinization. Abnormal LA metabolism is consistently linked to acne pathogenesis.

Multiple RCTs show oral and topical L. plantarum strains reduce acne lesion count, sebum triglycerides, and improve skin hydration. The CJLP55 strain demonstrated significant improvements over placebo at 12 weeks. Mechanisms involve modulation of skin microbiota and anti-inflammatory activity.

Clinical and preclinical evidence supports L. rhamnosus supplementation improving acne vulgaris outcomes via the gut-skin axis. A 12-week RCT using L. rhamnosus CECT 30031 found 50% of patients improved on the Acne Global Severity Scale versus 29% with placebo (p=0.03). Animal studies show L. rhamnosus reduces acne-associated inflammation by modulating gut microbiota and tryptophan metabolism. Gene-level studies document normalization of insulin-signaling and IGF-1 expression in skin.

Multiple clinical trials show oral lactoferrin reduces acne lesion counts, sebum production, and inflammatory grading. A 12-week double-blind RCT found significant decreases in inflammatory lesion count (38.6%), total lesion count (23.1%), and acne grade (20.3%) versus placebo. Topical lactoferrin-containing formulations have also demonstrated benefit in pilot trials.

Lavender essential oil demonstrates in vitro antimicrobial activity against Cutibacterium acnes (formerly P. acnes), the primary bacterium implicated in acne pathogenesis. A combination topical formulation of tea tree and lavender oils showed lesion-decreasing effects in a clinical investigation. Anti-inflammatory properties may additionally reduce acne-associated redness and swelling. Robust standalone clinical trial data remain limited.

Topical licorice extracts, particularly licochalcone A and glabridin, demonstrate anti-inflammatory, antimicrobial, and anti-androgenic properties relevant to acne pathophysiology. A double-blind study using a 2% licorice gel reported improvement in mild-to-moderate facial acne versus placebo. Evidence also supports reduction of post-inflammatory hyperpigmentation (PIH) via tyrosinase inhibition. The overall body of clinical evidence remains limited and larger trials are needed.

Mangosteen pericarp extracts demonstrate potent antibacterial activity against Cutibacterium acnes (formerly P. acnes) and Staphylococcus epidermidis in vitro. A hydrogel patch containing mangosteen pericarp showed bactericidal effects on acne-causing bacteria in a small clinical study. The active compound α-mangostin disrupts bacterial cell membrane integrity. Evidence is largely in vitro and early clinical, with no large RCTs yet.

Multiple randomized controlled trials and a 2025 systematic review with meta-analysis support modest efficacy of topical tea tree oil (TTO) for acne vulgaris. A landmark 1990 single-blind RCT (n=124) found 5% TTO gel comparable to 5% benzoyl peroxide in reducing inflamed lesions, with significantly fewer side effects. A 2025 PROSPERO-registered meta-analysis confirmed a modest reduction in acne severity with generally acceptable tolerability, though larger standardized trials are still needed.

Clinical evidence supports topical and oral silymarin for acne. A trial of 0.5% silymarin serum applied twice daily for 4 weeks reduced sebum secretion, lesion count, pigmentation, and erythema. A separate study found oral silybin over 8 weeks significantly reduced acne signs, with results comparable to doxycycline.

Monolaurin shows in vitro antibacterial activity against Staphylococcus aureus and related organisms implicated in acne. A cross-sectional laboratory study on pediatric skin infection isolates found 100% sensitivity of gram-positive organisms, including S. aureus, to monolaurin at 20 mg/mL. No controlled human trials specific to acne exist; evidence remains preclinical.

Topical NAG has been evaluated for mild-to-moderate acne based on its ability to modify exfoliation and keratinization in the stratum corneum. A study published in the Journal of the American Academy of Dermatology (JAAD, 2007) assessed its potential as an adjunctive acne agent. NAG's normalization of stratum corneum exfoliation and anti-inflammatory properties underlie this use.

NAC has been evaluated in clinical and dermatological studies for acne vulgaris, primarily due to its antioxidant and anti-inflammatory properties that may reduce oxidative stress in sebaceous follicles. A review in the Journal of Clinical and Aesthetic Dermatology found efficacy signals for NAC in acne vulgaris, both topically and orally. Evidence is preliminary and larger controlled trials are needed.

C. rotundus is described as having antiandrogenic properties (relevant to hormonal acne), and is documented as an anti-inflammatory and antimicrobial agent. The essential oil has been investigated clinically for skin conditions. Traditional use for skin diseases and dermatitis also covers acne-type presentations.

Omega-3 fatty acids (EPA/DHA) have fair-quality clinical evidence for acne, reducing cytokine-mediated inflammation by 40–50% in some studies and improving acne lesion counts. A nutraceutical systematic review (42 studies, 3,346 participants) identified omega-3 fatty acids among interventions with fair-quality evidence for acne. Omega-3 also reduces mucocutaneous side effects of isotretinoin in acne patients.

Omega-6 fatty acid metabolism, particularly linoleic acid (LA), is directly implicated in acne pathogenesis. Low LA levels in sebum are associated with comedone formation and follicular inflammation. Mendelian randomization evidence shows that higher LA levels and an elevated omega-6:omega-3 ratio are causally associated with increased acne risk, while the overall balance of fatty acids modulates sebaceous gland function.

Berberine and jatrorrhizine from Mahonia aquifolium bark have demonstrated in vitro inhibitory activity against Propionibacterium acnes isolates from acne lesions. Preparations containing Mahonia species have been reported to show clinical efficacy for acne vulgaris in traditional Chinese medicine. No large-scale RCTs specific to Oregon grape and acne exist, but the antimicrobial mechanism is well-characterized.

Retinyl palmitate has antimicrobial and anti-inflammatory properties relevant to acne, and exhibits sebaceous gland modulation. While stronger retinoids (tretinoin, isotretinoin) are the clinical gold standard, retinyl palmitate demonstrates anti-acne activity at higher concentrations with fewer side effects.

Palmitoleic acid (POA) is a naturally occurring component of skin surface lipids with documented antimicrobial activity against Gram-positive bacteria relevant to acne pathogenesis. Early clinical signals from a multi-nutrient regimen enriched in POA salts have been reported in adolescents with severe acne. Robust mechanistic human trials isolating POA remain limited.

Panthenol (dexpanthenol) has been studied as an adjunct in acne therapy, primarily for its anti-inflammatory and barrier-repair properties. A clinical study combined D-panthenol with hydrogen peroxide and salicylic acid and found a reduction in acne lesions with good tolerability. Its non-comedogenic, moisturizing properties help counteract skin barrier disruption caused by drying anti-acne agents.

Phellodendron amurense extract (Cortex Phellodendri) has demonstrated antimicrobial activity against Propionibacterium acnes, the anaerobic bacterium central to acne pathogenesis. A clinical study (Zhang et al., Clin Exp Dermatol 2018) examined a topical P. amurense facial mask for mild-to-moderate acne vulgaris. Preclinical patch studies confirm inhibition of P. acnes growth by P. amurense extract.

Propolis (bee glue) has well-documented antibacterial properties against C. acnes and has been evaluated in double-blind RCTs for acne. A 30-day double-blind RCT using a propolis–tea tree oil–aloe vera cream vs. erythromycin demonstrated comparable or superior reductions in total lesion counts and acne severity. Its bioactive constituents include flavonoids and phenolic acids with anti-inflammatory activity.

Resveratrol has been studied in a single-blind, vehicle-controlled pilot clinical trial for acne vulgaris, showing a 53.75% mean reduction in global acne grading score (GAGS) vs. 6.10% for vehicle, and a 66.7% mean reduction in microcomedone area on histologic analysis. It inhibits C. acnes biofilm formation and has anti-inflammatory and anti-androgenic properties.

Rosa canina demonstrates antimicrobial activity against Propionibacterium acnes (Cutibacterium acnes), the primary acne-causing pathogen, alongside anti-inflammatory and antioxidant properties relevant to acne pathology. Vitamin C in rosehip reduces post-acne scar pigmentation. A 2024 review specifically listed 'acne vulgaris' as a dermatological application of rosehip.

R. cordifolia root extracts have shown inhibitory activity against Cutibacterium acnes (formerly P. acnes) in vitro, suppressing both bacterial growth and ROS-mediated inflammatory responses. Polyherbal topical formulations containing R. cordifolia have been evaluated in acne vulgaris patients. The anti-acne effect is attributed to antibacterial, anti-inflammatory, and antioxidant constituents including anthraquinones and sitosterol.

Shea butter has low comedogenicity (rated 0–2/5) and possesses documented antibacterial properties that may reduce acne-causing bacteria. A 2022 study suggested topical application may decrease acne-causing bacteria on skin. Its non-pore-blocking profile and anti-inflammatory action support limited use in acne-prone skin, though direct clinical RCTs in acne patients are lacking.

A published split-face clinical trial in the Journal of Cutaneous Medicine and Surgery (2024) evaluated topical silymarin cream vs. salicylic acid peels in acne vulgaris, demonstrating clinical efficacy for silymarin. Its anti-inflammatory and immunomodulatory mechanisms (TNF-α, IL-1α suppression, COX/LOX inhibition) are well-characterized. It is used in cosmetic and dermatological preparations for acne.

Spearmint (Mentha spicata) has documented anti-androgenic properties, with RCTs demonstrating significant reductions in free and total testosterone in women, which could plausibly improve hormonal acne. Testosterone reductions were documented in both the Grant 2010 RCT and the Najafi 2024 RCT with twice-daily spearmint tea consumption. Acne has not been a primary endpoint in a dedicated RCT, but the androgen-reducing mechanism is clinically relevant.

Human studies reveal altered cutaneous lipid mediator profiles in acne, with reduced omega-3-derived SPMs. SPMs reduce IL-1β and keratinocyte inflammatory signaling relevant to comedone formation. A systematic review identified 7 human and preclinical studies examining SPMs in acne.

Succinic acid, produced by commensal skin bacteria such as Staphylococcus epidermidis, inhibits Cutibacterium acnes growth and reduces acne-associated inflammation in vitro and in vivo. Topical and intralesional applications have demonstrated antimicrobial and anti-inflammatory activity against acne-triggering bacteria. Its tolerability advantage over salicylic acid makes it an emerging option for sensitive acne-prone skin.

Sulforaphane's anti-inflammatory and antimicrobial properties are relevant to acne vulgaris pathophysiology. Via Nrf2/Keap1 activation and NF-κB suppression it reduces sebaceous gland inflammation and oxidative stress. Preclinical data are supportive; dedicated human RCTs in acne specifically remain limited as of 2026.

Tea tree oil (Melaleuca alternifolia) has well-documented antimicrobial and anti-inflammatory properties active against C. acnes. A randomized double-blind placebo-controlled trial (60 patients, 45 days) found 5% tea tree oil gel to be 3.55 times more effective than placebo in reducing total acne lesion count. A 2022 systematic review of RCTs confirmed its clinical use in acne dermatology.

Thyme tincture has demonstrated potent in vitro activity against Cutibacterium acnes (formerly P. acnes), the primary bacterium driving acne lesions. A Leeds Metropolitan University study found thyme tincture outperformed benzoyl peroxide in killing the acne bacterium. A subsequent PMC-published study formulated thyme essential oil as a nanoemulsion and tested it in an animal acne model with anti-inflammatory outcomes. Clinical human trials remain absent, so the evidence is currently preclinical.

In vitro and preclinical studies demonstrate that Thymus vulgaris essential oil and tinctures potently inhibit Cutibacterium acnes (formerly P. acnes), the primary bacterium implicated in acne. A Leeds Metropolitan University study found thyme tincture outperformed standard concentrations of benzoyl peroxide in killing the bacterium. A 2022 PMC-indexed study confirmed thyme EO had the most potent antimicrobial and antibiofilm activity against C. acnes and S. epidermidis among five tested essential oils, with in vivo animal models showing suppressed inflammatory response.

Turmeric (Curcuma longa) contains curcumin and has anti-inflammatory and antibacterial properties evaluated in clinical studies for acne. A 2022 systematic review of herbal medicine for acne vulgaris (34 clinical trials, 1,753 participants) cited turmeric preparations in its evaluation. Multiple evidence reviews list turmeric/curcuminoids among plant-derived anti-acne nutraceuticals with antioxidant, anti-inflammatory, and antibacterial activity.

Oral vitamin A (retinol) and its acid derivative (retinoic acid) have been studied in multiple clinical trials for acne vulgaris. A 2022 PubMed literature review identified 8 clinical trials showing acne improvement with oral vitamin A. High-dose retinol (300,000–500,000 IU/day) demonstrated efficacy for severe inflammatory acne, with mean improvement in 7 weeks to 4 months. Topical vitamin A acid (tretinoin) is among the most established topical acne treatments.

Topical niacinamide (4–5%) has been studied in multiple clinical trials for acne vulgaris, demonstrating anti-inflammatory and sebum-regulating effects. A controlled trial found 4% niacinamide gel to be comparably effective to 1% clindamycin gel, with the advantage of not promoting antibiotic resistance. A 2017 PubMed review found that 6 of 8 studies using topical nicotinamide showed significant acne reduction versus baseline or standard care.

Niacinamide (topical and oral) reduces acne by decreasing sebum production, inhibiting C. acnes, and exerting anti-inflammatory effects. A 2025 systematic review (Oxford/PMC) confirmed its inclusion among cosmeceuticals with clinical trial evidence for acne. Six of eight trials of topical niacinamide showed significant acne reduction vs. baseline or equivalence to standard care.

Pantothenic acid (vitamin B5) has fair-quality clinical evidence for acne, including a 12-week double-blind RCT showing a 68.2% greater reduction in total facial lesions vs. placebo. It is thought to regulate sebum production via coenzyme A metabolism and keratinocyte differentiation. A separate RCT (n=41) confirmed superior IGA success rate vs. placebo.

Vitamin D deficiency is significantly more common in acne patients (standardized mean difference -7.66 ng/mL vs. non-acne controls, per systematic review). Vitamin D supplementation in deficient acne patients reduces sebum production, inhibits C. acnes development, and decreases inflammatory lesions. A good-quality clinical study was identified in a nutraceutical systematic review (42 studies, 3,346 participants).

Vitamin D3 (cholecalciferol) is the specific form of vitamin D studied in acne clinical trials, with 1,000 IU/day associated with improvement in inflammatory acne lesions in deficient patients. It reduces sebum production, inhibits C. acnes, and modulates immune response. Deficiency is significantly more prevalent in acne patients than controls.

Zinc (topical and oral) is among the most clinically studied nutrients for acne, with anti-inflammatory, antimicrobial, and anti-androgenic properties. A Cochrane review of 49 RCTs included topical zinc as an evaluated agent, and multiple double-blind trials of oral zinc sulfate have shown significant reductions in inflammatory lesions. Evidence is consistent though effect sizes are moderate.

Tartaric acid is classified as an alpha-hydroxy acid (AHA) and is used topically as a keratolytic and exfoliating agent in skincare products targeting acne. Its action includes loosening dead skin cells, unclogging pores, and mild antimicrobial activity on the skin surface. Direct clinical trials isolating tartaric acid for acne are absent, but its use is well-established within the broader AHA cosmetic tradition.

Argan oil has a traditional Moroccan use for treating skin pimples and juvenile acne. Its anti-sebum and anti-inflammatory properties are proposed mechanisms. Clinical evidence specific to acne is sparse, with claims largely based on traditional use and in vitro data.

Arnica has a documented traditional and cosmetic use applied topically to acne, attributed to its antimicrobial and anti-inflammatory properties. The sesquiterpene helenalin shows antibacterial activity against relevant pathogens including Staphylococcus aureus. No dedicated clinical trials for acne specifically have been published; the basis is traditional use and pharmacological plausibility.

Black walnut hull has been used traditionally as a topical remedy for acne, attributed to its astringent tannins and antimicrobial juglone content. The tannins tighten the epidermis and reduce surface bacteria. No controlled clinical trials in acne patients have been conducted.

Cajuput oil is documented in Malay traditional medicine for treating acne, attributed to its antimicrobial properties against skin-colonizing bacteria. In vitro studies confirm antibacterial activity of M. cajuputi extracts against Staphylococcus aureus and Staphylococcus epidermidis, which are implicated in acne pathogenesis. No clinical trials in acne patients have been conducted specifically on cajuput.

Calendula has a long ethnobotanical record of topical use for acne, attributed to its antimicrobial and anti-inflammatory properties. In vitro data confirm activity against acne-associated bacteria, and calendula tinctures and suspensions are traditionally applied to blemish-prone skin. No dedicated human RCT specifically for acne has been published to date.

Cowpea flour is traditionally used in Ayurvedic practice as a topical face mask ingredient for acne and skin pigmentation. This represents documented traditional use without supporting clinical trial data.

Chickweed has traditional use as an astringent and anti-inflammatory wash or topical preparation for acne and spots. Its astringent and mild antimicrobial properties are the basis of this use. No clinical trials in humans have tested it specifically for acne.

Cleavers has a long tradition in European herbalism for hot, inflamed skin conditions including acne, attributed to its lymphatic-draining and cooling properties. Historically, both internal teas and topical washes were used. No human clinical trials exist; this remains an empirical traditional use.

Coix seed has long been used in TCM and East Asian cosmetic traditions to clear 'damp-heat' manifesting as acne and skin blemishes. Fermented and hydrolyzed coix preparations have been investigated for skin barrier and anti-inflammatory effects in cell and animal models, but robust human RCTs specifically for acne are lacking.

Dandelion is traditionally used for inflammatory skin conditions including acne across European, Chinese, and North American herbal traditions. Its antimicrobial, anti-inflammatory, and liver-depurative properties are cited as the rationale. No clinical dermatological trials for acne exist.

Dog Rose has a documented traditional use in the management of acne, particularly via distilled rose water or topical preparations. The ScienceDirect Rosa canina and Cancer review (2024) records 'distilled water of rose used for the management of acne' as a traditional application. Rosehip oil's anti-inflammatory and antibacterial properties provide a mechanistic basis.

Eucalyptus oil has preliminary evidence from an uncontrolled trial in acne vulgaris showing positive results, but this study had only five participants and methodological limitations. Its antimicrobial activity against skin bacteria provides plausible mechanistic support. The evidence is insufficient to classify as scientific; it is better characterized as emerging traditional/preliminary use.

Forsythia is one of the 50 fundamental herbs in TCM and is traditionally used in formulas addressing acne and skin infections, exploiting its heat-clearing and detoxifying properties. It appears in classical formulas and modern TCM practice for acne. Preclinical data support antimicrobial and anti-inflammatory actions, but no dedicated human clinical trials for acne exist.

Goldenseal is used in traditional herbal practice for acne, based on its antimicrobial activity against skin pathogens and anti-inflammatory properties. No clinical trials of goldenseal for acne have been identified in the literature.

Traditional medicine in India, Tibet, China, and Sri Lanka has used amla for acne for centuries. Its documented antimicrobial, anti-inflammatory, and antioxidant properties are mechanistically relevant. No clinical RCTs for acne have been identified.

Honeysuckle is a chief herb in the classical TCM acne formula Cuo Chuan Jian Ji (Acne Decoction) and is widely used topically in modern cosmeceuticals for its anti-inflammatory and antimicrobial properties. Its soothing, skin-clearing actions in acne-prone and sensitive skin are supported by in vitro data but not yet by published human clinical trials specific to acne.

Indian sarsaparilla (Hemidesmus indicus) is documented in Ayurvedic texts as 'Sariva', traditionally used for inflammatory and eruptive skin conditions including acne. Its anti-inflammatory and antimicrobial phytoconstituents underpin this use. Preclinical evidence of anti-acne activity has been noted in plant extract studies, but no controlled human clinical trials exist.

Myrrh has traditionally been used for skin infections including acne due to its antimicrobial and anti-inflammatory properties. Topical preparations are used in herbal traditions for spots, boils, and infected skin. Scientific evidence is limited to in vitro antimicrobial data relevant to acne pathogens.

Neem (Azadirachta indica) has a long history of traditional use in Ayurvedic medicine for acne and skin infections, attributed to antibacterial, antifungal, and anti-inflammatory properties of its bioactive compounds (nimbidin, nimbidol, azadirachtin). An RCT comparing a neem, tea tree oil, and aloe vera gel combination to benzoyl peroxide found comparable results with fewer side effects.

Colloidal oatmeal has a traditional use in skin care for a variety of inflammatory conditions including acne-prone skin, leveraging its anti-inflammatory, sebum-absorbing, and skin-barrier-supporting properties. Clinical evidence is available for its anti-inflammatory mechanisms but specific RCTs in acne are limited.

Orange peel is used in traditional skincare practices across Asian and Middle Eastern cultures for acne reduction, attributed to its antimicrobial, astringent, and antioxidant properties. Vitamin C from orange supports skin clarity by reducing oxidative stress. Clinical RCT evidence for orange specifically in acne is absent.

Red clover has a documented traditional use for acne through its historical role as an 'alterative' or blood-purifying herb. Multiple monograph sources list acne as a traditional indication. The EBSCO Research database notes preliminary evidence may be beneficial for acne. No dedicated clinical trials have been identified.

Sarsaparilla has a documented traditional use for acne, particularly androgen-related adolescent acne, attributed to its anti-inflammatory and putative hormone-modulating saponins. Some experimental support exists but no controlled clinical trials have confirmed efficacy. The herb is classified as an alterative, historically used to 'purify' the blood and reduce skin eruptions.

Saw palmetto is proposed to reduce acne by inhibiting 5-alpha-reductase, thereby lowering DHT and reducing androgen-driven sebum overproduction. Its dual inhibition of COX and 5-lipoxygenase pathways may further reduce inflammatory lesions. Direct clinical trials in acne are lacking; evidence is largely mechanistic and extrapolated from androgenic conditions such as PCOS. Traditional and dermatological herbal use documents this application.

Schizonepeta is used in TCM for skin infections and inflammatory skin lesions including boils and surface abscesses, under the category of wind-heat skin conditions. Its antibacterial and anti-inflammatory properties are documented in preclinical research. No clinical evidence specifically for acne exists.

Sarsaparilla has documented traditional and some early experimental use for acne, attributed to its putative endotoxin-binding and anti-androgenic properties. Clinical research has validated traditional use for skin conditions including acne, though formal RCT evidence is lacking.

Sophora root (Ku Shen) is documented in TCM for treating pyoderma (skin purulence) and skin conditions attributed to damp-heat, including acne. Its antimicrobial and anti-inflammatory properties provide mechanistic support, and it is noted in herbal medicine references for acne applications.

Brewer's yeast has a long traditional use for acne, attributed to its chromium content (which may modulate insulin and sebum production) and B-vitamins (especially B3 and B5). One older double-blind study noted improvement in ~80% of subjects after 5 months of supplementation, though evidence quality is low and studies used chromium-enriched preparations specifically. Modern clinical evidence is sparse.